| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.900 | None | 0.946 | 13 | 0 | 1991 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.700 | None | 0.972 | 9 | 0 | 1997 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.700 | None | 0.984 | 2 | 0 | 2008 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.936 | 5 | 0 | 1994 | 2020 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.600 | strong | 0.938 | 1 | 0 | 2001 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.991 | 12 | 0 | 1988 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 0.960 | 6 | 0 | 1999 | 2019 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
disease | 0.400 | None | 0.980 | 5 | 0 | 1991 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.979 | 3 | 0 | 2004 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.920 | 3 | 0 | 2001 | 2019 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
disease | 0.400 | None | 0.933 | 3 | 0 | 2002 | 2018 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.958 | 3 | 0 | 1994 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1994 | 2020 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1993 | 2020 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.400 | None | 0.893 | 1 | 0 | 2007 | 2019 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1993 | 2019 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
DNA topoisomerase II alpha | 0.497 | 0.731 | 0.99 |
|
disease | 0.350 | None | 1.000 | 1 | 0 | 2005 | 2020 | ||||||||
|
midkine | 0.494 | 0.808 | 0.23 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
chloride voltage-gated channel 3 | 0.621 | 0.615 | 1.00 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2003 | 2013 | ||||||||
|
ATPase Na+/K+ transporting subunit beta 2 | 0.705 | 0.308 | 7.4E-02 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2003 | 2006 |